CYTK

Cytokinetics, Incorporated

Insider Trades

NameValueActionPriceCurrent Price
Malik Fady IbrahamEVP Research & Development
$238k3.5k shares
SellJun 9, 2026
$67.98
$67.90
Callos AndrewEVP, Chief Commercial Officer
$104k1.7k shares
SellMar 16, 2026
$61.03
--
Callos AndrewEVP, Chief Commercial Officer
$120k1.9k shares
SellMar 18, 2026
$62.07
--
Blum Robert IDirector, Officer: President & CEO
$1.5M23.9k shares
SellMar 17, 2026
$62.15
--
Blum Robert IDirector, Officer: President & CEO
$788k12.7k shares
SellMar 17, 2026
$62.15
--
Malik Fady IbrahamEVP Research & Development
$273k4.4k shares
SellMar 17, 2026
$62.15
--

News

globenewswire.comCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.comJun 17zacks.comCytokinetics Gains 18.4% Year to Date: How to Play the Stock?zacks.comJun 17seekingalpha.comCytokinetics, Incorporated (CYTK) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.comJun 9globenewswire.comCytokinetics Announces Call for Proposals for Annual Corporate Giving Programglobenewswire.comJun 8zacks.comWhy Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?zacks.comJun 4